Header Logo

Connection

Barry Maron to Athletes

This is a "connection" page, showing publications Barry Maron has written about Athletes.
Connection Strength

16.944
  1. Maron MS, Rowin EJ, Maron BJ. Letter by Maron et al Regarding Article, "Sudden Cardiac Death in National Collegiate Athletic Association Athletes". Circulation. 2024 Sep 17; 150(12):e255-e256.
    View in: PubMed
    Score: 0.841
  2. Harris KM, Mackey-Bojack S, Fisher G, Nwaudo D, Maron BJ. Arrhythmogenic Mitral Valve Prolapse Revisited: A Not Uncommon Cause of Youthful Sudden Death in Athletes and Women. Am J Med. 2025 Jan; 138(1):156-160.
    View in: PubMed
    Score: 0.835
  3. Harris KM, Mackey-Bojack S, Bennett M, Nwaudo D, Duncanson E, Maron BJ. Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes. Am J Cardiol. 2021 03 15; 143:131-134.
    View in: PubMed
    Score: 0.648
  4. Maron BJ, Estes NAM, Maron MS. Is It Fair to Screen Only Competitive Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field? Am J Cardiol. 2018 04 15; 121(8):1008-1010.
    View in: PubMed
    Score: 0.531
  5. Maron BJ, Nishimura RA, Maron MS. Shared decision-making in HCM. Nat Rev Cardiol. 2017 03; 14(3):125-126.
    View in: PubMed
    Score: 0.495
  6. Maron BJ, Maron BA. Revisiting Athlete's Heart Versus Pathologic Hypertrophy: ARVC and the Right Ventricle. JACC Cardiovasc Imaging. 2017 04; 10(4):394-397.
    View in: PubMed
    Score: 0.480
  7. Maron BJ, Haas TS, Ahluwalia A, Murphy CJ, Garberich RF. Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry. Am J Med. 2016 Nov; 129(11):1170-1177.
    View in: PubMed
    Score: 0.468
  8. Maron BJ, Harris KM, Thompson PD, Eichner ER, Steinberg MH. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e343-5.
    View in: PubMed
    Score: 0.454
  9. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2343-2349.
    View in: PubMed
    Score: 0.454
  10. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM, Cooper LT, Link MS, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2362-2371.
    View in: PubMed
    Score: 0.454
  11. Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2356-2361.
    View in: PubMed
    Score: 0.454
  12. Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2424-2428.
    View in: PubMed
    Score: 0.454
  13. Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2398-2405.
    View in: PubMed
    Score: 0.454
  14. Maron BJ, Harris KM, Thompson PD, Eichner ER, Steinberg MH. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2444-2446.
    View in: PubMed
    Score: 0.454
  15. Link MS, Estes NAM, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2439-2443.
    View in: PubMed
    Score: 0.454
  16. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA, Cooper LT, Link MS, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e273-80.
    View in: PubMed
    Score: 0.454
  17. Maron BJ. Historical Perspectives on Sudden Deaths in Young Athletes With Evolution over 35 Years. Am J Cardiol. 2015 Nov 01; 116(9):1461-8.
    View in: PubMed
    Score: 0.448
  18. Maron BJ, Winkel BG, Tfelt-Hansen J. Cardiovascular screening for young athletes--reply. JAMA. 2015 Apr 28; 313(16):1674-5.
    View in: PubMed
    Score: 0.438
  19. Maron BJ, Winkel BG, Tfelt-Hansen J. Perspectives on cardiovascular screening. JAMA. 2015 Jan 06; 313(1):31-2.
    View in: PubMed
    Score: 0.429
  20. Maron BJ, Friedman R. To the editor--Participation screening for athletes. Heart Rhythm. 2014 Dec; 11(12):e199-200.
    View in: PubMed
    Score: 0.419
  21. Quattrini FM, Pelliccia A, Assorgi R, DiPaolo FM, Squeo MR, Culasso F, Castelli V, Link MS, Maron BJ. Benign clinical significance of J-wave pattern (early repolarization) in highly trained athletes. Heart Rhythm. 2014 Nov; 11(11):1974-82.
    View in: PubMed
    Score: 0.417
  22. Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol. 2014 Apr 29; 63(16):1636-43.
    View in: PubMed
    Score: 0.404
  23. Maron BJ, Murphy CJ, Haas TS, Ahluwalia A, Garberich RF. Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes. Int J Cardiol. 2014 May 15; 173(3):369-72.
    View in: PubMed
    Score: 0.404
  24. Maron BJ, Harris KM, Haas TS, Eichner ER. Reply: To PMID 22809753. Am J Cardiol. 2013 Jan 01; 111(1):149.
    View in: PubMed
    Score: 0.373
  25. Maron BJ, Haas TS, Ahluwalia A, Rutten-Ramos SC. Incidence of cardiovascular sudden deaths in Minnesota high school athletes. Heart Rhythm. 2013 Mar; 10(3):374-7.
    View in: PubMed
    Score: 0.371
  26. Harris KM, Haas TS, Eichner ER, Maron BJ. Sickle cell trait associated with sudden death in competitive athletes. Am J Cardiol. 2012 Oct 15; 110(8):1185-8.
    View in: PubMed
    Score: 0.362
  27. Maron BJ. Counterpoint/Mandatory ECG screening of young competitive athletes. Heart Rhythm. 2012 Nov; 9(11):1897.
    View in: PubMed
    Score: 0.355
  28. Maron BJ. Counterpoint: Mandatory ECG screening of young competitive athletes. Heart Rhythm. 2012 Oct; 9(10):1646-9.
    View in: PubMed
    Score: 0.353
  29. Pelliccia A, Maron MS, Maron BJ. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy. Prog Cardiovasc Dis. 2012 Mar-Apr; 54(5):387-96.
    View in: PubMed
    Score: 0.352
  30. Thomas M, Haas TS, Doerer JJ, Hodges JS, Aicher BO, Garberich RF, Mueller FO, Cantu RC, Maron BJ. Epidemiology of sudden death in young, competitive athletes due to blunt trauma. Pediatrics. 2011 Jul; 128(1):e1-8.
    View in: PubMed
    Score: 0.336
  31. Pelliccia A, Di Paolo FM, De Blasiis E, Quattrini FM, Pisicchio C, Guerra E, Culasso F, Maron BJ. Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes. Circulation. 2010 Aug 17; 122(7):698-706, 3 p following 706.
    View in: PubMed
    Score: 0.316
  32. Pelliccia A, Kinoshita N, Pisicchio C, Quattrini F, Dipaolo FM, Ciardo R, Di Giacinto B, Guerra E, De Blasiis E, Casasco M, Culasso F, Maron BJ. Long-term clinical consequences of intense, uninterrupted endurance training in olympic athletes. J Am Coll Cardiol. 2010 Apr 13; 55(15):1619-25.
    View in: PubMed
    Score: 0.309
  33. Maron BJ. National electrocardiography screening for competitive athletes: Feasible in the United States? Ann Intern Med. 2010 Mar 02; 152(5):324-6.
    View in: PubMed
    Score: 0.307
  34. Maron MS, Mitten M, Borchers J, Rowin EJ, Maron BJ. Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease. J Am Coll Cardiol. 2023 08 29; 82(9):828-832.
    View in: PubMed
    Score: 0.194
  35. Maron MS, Rowin EJ, Bonaventura J, Maron BJ. Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field? Am J Cardiol. 2023 08 01; 200:236-238.
    View in: PubMed
    Score: 0.193
  36. Bonaventura J, Rowin EJ, Maron MS, Maron BJ. Risks of the Athletic Field Revisited: Report of Unusual Occurrences of Cardiac Arrest and Sudden Death in Professional Soccer Players. Am J Med. 2023 03; 136(3):315-321.
    View in: PubMed
    Score: 0.186
  37. Udelson JE, Rowin EJ, Maron BJ. Return to Play for Athletes After COVID-19 Infection: The Fog Begins to Clear. JAMA Cardiol. 2021 09 01; 6(9):997-999.
    View in: PubMed
    Score: 0.170
  38. Thiene G, Rizzo S, Schiavon M, Maron MS, Zorzi A, Corrado D, Maron BJ, Basso C. Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People. J Am Coll Cardiol. 2019 06 18; 73(23):3031-3032.
    View in: PubMed
    Score: 0.146
  39. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NAM, Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Jordaens L, Law I, Loomis M, Willems R, Barth C, Broos K, Brandt C, Dziura J, Li F, Simone L, Vandenberghe K, Cannom D. Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry. Circulation. 2017 06 06; 135(23):2310-2312.
    View in: PubMed
    Score: 0.127
  40. Maron BJ, Haas TS, Duncanson ER, Garberich RF, Baker AM, Mackey-Bojack S. Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes? Am J Cardiol. 2016 Apr 15; 117(8):1339-41.
    View in: PubMed
    Score: 0.116
  41. Mitten MJ, Zipes DP, Maron BJ, Bryant WJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2447-2450.
    View in: PubMed
    Score: 0.114
  42. Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e303-9.
    View in: PubMed
    Score: 0.114
  43. Link MS, Estes NA, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e339-42.
    View in: PubMed
    Score: 0.114
  44. Harris KM, Tung M, Haas TS, Maron BJ. Under-recognition of aortic and aortic valve disease and the risk for sudden death in competitive athletes. J Am Coll Cardiol. 2015 Mar 03; 65(8):860-862.
    View in: PubMed
    Score: 0.108
  45. Verdile L, Maron BJ, Pelliccia A, Spataro A, Santini M, Biffi A. Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities. Heart Rhythm. 2015 Jan; 12(1):78-85.
    View in: PubMed
    Score: 0.105
  46. Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD. Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2014 Oct 07; 64(14):1479-514.
    View in: PubMed
    Score: 0.105
  47. Caselli S, Maron MS, Urbano-Moral JA, Pandian NG, Maron BJ, Pelliccia A. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2014 Nov 01; 114(9):1383-9.
    View in: PubMed
    Score: 0.104
  48. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NA, Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Law I, Loomis M, Barth C, Brandt C, Dziura J, Li F, Cannom D. Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry. Circulation. 2013 May 21; 127(20):2021-30.
    View in: PubMed
    Score: 0.096
  49. Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol. 2012 Oct 01; 110(7):1027-32.
    View in: PubMed
    Score: 0.090
  50. Biffi A, Maron BJ, Culasso F, Verdile L, Fernando F, Di Giacinto B, Di Paolo FM, Spataro A, Delise P, Pelliccia A. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. Am J Cardiol. 2011 Mar 01; 107(5):697-703.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.